A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction.

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with ...

HealthDay News — For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction, according to a study ...

The researchers found that participants who lost at least 35% of their body weight from baseline to week 72 had mean changes of up to –14.2 and –9.2 mm Hg for systolic and diastolic blood ...

Insurance coverage for weight-loss drugs has recently increased, but typically only covers branded versions, according to ...

ALONG with rapid fat loss, weight loss jabs have been linked to a decrease in muscle mass. But scientists say one injection – ...

A major change in the rules starts on Monday and you must have four medical conditions as well as a specific BMI ...

Prescriptions for the weight-loss jab Mounjaro are now being offered at GP surgeries in England - but only for patients who ...

A nurse has warned about a common Mounjaro ‘mistake’ that can increase people’s risk of deadly organ damage.

Last week, Australia’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a ...